Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-02 4:45 pm Purchase | 2024-01-02 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN | Markey John | 24,788 6.500% | 24,788 (New Position) | Filing History |
| 2024-01-02 4:19 pm Sale | 2024-01-02 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN | Markey John | 24,788 6.500% | -4,102 (-14.20%) | Filing History |
| 2023-11-17 11:32 am Purchase | 2023-11-17 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN | Markey John | 28,889 7.600% | 4,417 (+18.05%) | Filing History |
| 2023-11-06 11:35 am Purchase | 2023-11-06 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN | Markey John | 24,473 6.400% | 24,473 (New Position) | Filing History |
| 2023-08-07 07:00 am Purchase | 2023-08-07 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN | Markey John | 23,295 10.700% | 2,273 (+10.81%) | Filing History |
| 2023-07-17 07:00 am Purchase | 2023-07-17 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN | Markey John | 21,023 11.100% | 2,244 (+11.95%) | Filing History |
| 2023-07-07 07:00 am Purchase | 2023-07-07 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN | Markey John | 18,778 9.900% | 2,699 (+16.78%) | Filing History |
| 2023-06-30 08:40 am Purchase | 2023-06-30 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN | Markey John | 16,080 8.500% | 625 (+4.04%) | Filing History |
| 2023-06-22 10:50 am Sale | 2023-06-22 | 13G | T2 Biosystems, Inc. TTOO | Markey John | 0 0.000% | -43,000 (Position Closed) | Filing History |
| 2023-06-16 07:00 am Purchase | 2023-06-16 | 13G | T2 Biosystems, Inc. TTOO | Markey John | 43,000 17.300% | 6,500 (+17.81%) | Filing History |
| 2023-06-14 07:00 am Purchase | 2023-06-14 | 13G | T2 Biosystems, Inc. TTOO | Markey John | 36,500 14.700% | 11,850 (+48.07%) | Filing History |
| 2023-06-12 10:39 am Purchase | 2023-06-12 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN | Markey John | 15,455 9.900% | 2,386 (+18.26%) | Filing History |
| 2023-06-12 09:22 am Purchase | 2023-06-12 | 13G | T2 Biosystems, Inc. TTOO | Markey John | 24,650 9.900% | 24,650 (New Position) | Filing History |
| 2023-05-26 10:23 am Purchase | 2023-05-25 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN | Markey John | 13,068 8.400% | 2,382 (+22.29%) | Filing History |
| 2023-05-26 10:23 am Sale | 2023-05-25 | 13G | Creative Medical Technology Holdings, Inc. CELZ | Markey John | 0 0.000% | -71,757 (Position Closed) | Filing History |
| 2023-05-17 3:49 pm Purchase | 2023-05-17 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN | Markey John | 10,687 6.850% | 3,184 (+42.43%) | Filing History |
| 2023-05-01 9:49 pm Purchase | 2023-04-28 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN | Markey John | 7,503 6.500% | 7,503 (New Position) | Filing History |
| 2023-05-01 9:49 pm Purchase | 2023-04-28 | 13G | Creative Medical Technology Holdings, Inc. CELZ | Markey John | 71,757 5.100% | 71,757 (New Position) | Filing History |
| 2023-03-13 09:21 am Purchase | 2023-03-13 | 13G | Edible Garden AG Incorporated EDBL | Markey John | 6,000 6.000% | 6,000 (New Position) | Filing History |
| 2022-12-27 11:09 am Sale | 2022-12-14 | 13G | Vallon Pharmaceuticals, Inc. VLON | Markey John | 0 0.000% | -28,316 (Position Closed) | Filing History |